Has James Devries, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,151 in general payments to James Devries, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Devries, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Devries, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Devries, MD

Interventional Cardiology · Lebanon, NHNPI 1225088826

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Edwards Lifesciences at 50.7% of the total.

$19,151in general payments, 2019–2025

Across 76 payments — averaging $251.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$10K
Philips North America LLC$5K
Medtronic$3K
Abbott$902
Boston Scientific$240
Alnylam Pharmaceuticals Inc.$37
plus $33 from 2 others

$559,039in research payments, 2019–2025

Across 111 payments — averaging $5036.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$318K
Medtronic$177K
Tryton Medical, Inc.$54K
Boston Scientific$10K

What the payments were for

Consulting fees$4,68824%
Travel & lodging$9,84351%
Food & beverage$4,62124%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	28	$9,704
Philips North America LLC	2	$5,340
Medtronic(2 entities)	28	$2,895
Abbott	12	$902
Boston Scientific	3	$240
Alnylam Pharmaceuticals Inc.	1	$37
Spectrawave, Inc	1	$19
Angiodynamics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$5,391
Spectranetics Undiv$5,293
ONYX FRONTIER$1,002
EVOQUE$851
COREVALVE EVOLUT R$742
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$413
RESOLUTE ONYX$309
SAPIEN 3 Ultra RESILIA$246
MitraClip$172
SYNERGY$163
PORTICO$151
NAVITOR$150

How this compares

$19,151 in reported general payments places this provider in the 80th percentile of 26 interventional cardiology providers in New Hampshire.

See all interventional cardiology providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$276,912

Medicare patients

553

Services billed

1,306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	69	$45,836
Metoprolol Succinate	101	$1,332
Atorvastatin Calcium	75	$1,260
Ranolazine ErRanolazine	16	$606
Rosuvastatin Calcium	37	$588
Amlodipine Besylate	50	$507
Lisinopril	39	$377
ClopidogrelClopidogrel Bisulfate	31	$281
Losartan Potassium	29	$211
Furosemide	21	$196
Nitroglycerin	14	$156
Spironolactone	18	$154
Atenolol	11	$64
Metoprolol Tartrate	13	$38
Amoxicillin	15	$21

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Lebanon

Hannah ChaudryLebanon$20K
Eric RothsteinLebanon$20K
Aaron KaplanLebanon$13K
Bruce FriedmanLebanon$1K
Alina RobertLebanon$1K
John JayneLebanon$96
John RobbLebanon$0
Shahab MoossaviConcord$36K
Nitish SharmaDover$23K
Rodrigo Mendirichaga MaganaDover$21K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →